IL71017A - Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha - Google Patents
Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alphaInfo
- Publication number
- IL71017A IL71017A IL71017A IL7101784A IL71017A IL 71017 A IL71017 A IL 71017A IL 71017 A IL71017 A IL 71017A IL 7101784 A IL7101784 A IL 7101784A IL 71017 A IL71017 A IL 71017A
- Authority
- IL
- Israel
- Prior art keywords
- diagnosis
- purification
- detection
- cell lines
- monoclonal antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833306060 DE3306060A1 (de) | 1983-02-22 | 1983-02-22 | Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL71017A0 IL71017A0 (en) | 1984-05-31 |
| IL71017A true IL71017A (en) | 1987-12-31 |
Family
ID=6191474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL71017A IL71017A (en) | 1983-02-22 | 1984-02-21 | Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0119476A3 (da) |
| JP (1) | JPS59224687A (da) |
| DE (1) | DE3306060A1 (da) |
| DK (1) | DK85084A (da) |
| ES (2) | ES529912A0 (da) |
| FI (1) | FI840675L (da) |
| IL (1) | IL71017A (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5196323A (en) * | 1985-04-27 | 1993-03-23 | Boehringer Ingelheim International Gmbh | Process for preparing and purifying alpha-interferon |
| DE3515336C2 (de) * | 1985-04-27 | 1994-01-20 | Boehringer Ingelheim Int | Verfahren zur Herstellung und Reinigung von â-Interferon |
| AU6032786A (en) * | 1985-07-25 | 1987-01-29 | University Of Minnesota | Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo |
| GB8615353D0 (en) * | 1986-06-24 | 1986-07-30 | Antibioticos Sa | Interferon |
| DE3633323A1 (de) * | 1986-10-01 | 1988-04-07 | Boehringer Ingelheim Int | Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega |
| SE468251B (sv) | 1989-06-20 | 1992-11-30 | Bionative Ab | Reningsprocess foer interferon |
| SK386392A3 (en) * | 1990-07-10 | 1994-08-10 | Boehringer Ingelheim Int | Interferon alpha |
| US7087726B2 (en) | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
| WO2008070135A2 (en) | 2006-12-06 | 2008-06-12 | Medimmune, Llc. | Methods of treating systemic lupus erythematosus |
| CA2686861A1 (en) | 2007-05-03 | 2008-11-13 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
| HUE025787T2 (en) | 2007-11-05 | 2016-05-30 | Medimmune Llc | Method for treating scleroderma |
| MX2010008698A (es) | 2008-02-08 | 2010-12-20 | Medimmune Llc | Marcadores de enfermedad y usos de los mismos. |
| HRP20170091T1 (hr) | 2009-09-03 | 2017-03-24 | Medimmune, Llc | Dijagnostika interferona tip 1 |
| US20220162325A1 (en) | 2019-02-15 | 2022-05-26 | Astrazeneca Ab | Type i interferon-mediated disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI77877C (fi) * | 1979-04-20 | 1989-05-10 | Technobiotic Ltd | Foerfarande foer framstaellning och rening av human le-formig interferonprotein. |
| DE3177276D1 (de) * | 1980-04-11 | 1992-04-23 | Celltech Ltd | Monoklonale antikoerper. |
| FR2500754B1 (fr) * | 1981-02-27 | 1986-06-27 | Hoffmann La Roche | Anticorps monoclonaux |
| JPS60500864A (ja) * | 1983-02-04 | 1985-06-06 | ワドリ、テクナラジズ、インコーパレイティド | 近縁関係にあるが別個のタンパク質間に存在する共通決定基に対して特異的なハイブリド−マ抗体の製造および特性づけ |
| GB8303165D0 (en) * | 1983-02-04 | 1983-03-09 | Secher D S | Monoclonal antibody |
-
1983
- 1983-02-22 DE DE19833306060 patent/DE3306060A1/de not_active Withdrawn
-
1984
- 1984-02-16 EP EP84101610A patent/EP0119476A3/de not_active Withdrawn
- 1984-02-20 FI FI840675A patent/FI840675L/fi not_active Application Discontinuation
- 1984-02-20 JP JP59030135A patent/JPS59224687A/ja active Pending
- 1984-02-21 ES ES529912A patent/ES529912A0/es active Granted
- 1984-02-21 DK DK85084A patent/DK85084A/da not_active Application Discontinuation
- 1984-02-21 IL IL71017A patent/IL71017A/xx not_active IP Right Cessation
- 1984-08-30 ES ES535509A patent/ES8505409A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI840675A7 (fi) | 1984-08-23 |
| ES8503371A1 (es) | 1985-02-16 |
| EP0119476A2 (de) | 1984-09-26 |
| ES535509A0 (es) | 1985-05-16 |
| FI840675A0 (fi) | 1984-02-20 |
| JPS59224687A (ja) | 1984-12-17 |
| DE3306060A1 (de) | 1984-08-23 |
| DK85084A (da) | 1984-08-23 |
| DK85084D0 (da) | 1984-02-21 |
| ES8505409A1 (es) | 1985-05-16 |
| FI840675L (fi) | 1984-08-23 |
| EP0119476A3 (de) | 1987-04-08 |
| IL71017A0 (en) | 1984-05-31 |
| ES529912A0 (es) | 1985-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL76142A0 (en) | Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof | |
| IL67721A (en) | Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies | |
| EP0345461A3 (en) | Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests | |
| EP0260610A3 (en) | Monoclonal antibodies against human tumour necrotic factor (tnf), and their use | |
| IL71621A0 (en) | Use of alpha factor sequences in yeast expression systems | |
| GB2109684B (en) | Serum thymic factor for use in the treatment of immuno deficiency | |
| AU3227684A (en) | Detection of antibodies in human serum | |
| IL71017A (en) | Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha | |
| AU6032786A (en) | Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo | |
| GR871298B (en) | Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections | |
| AU4688785A (en) | Monoclonal antibodies to glycoconjugates and use in cancer detection and treatment | |
| EP0240344A3 (en) | Monoclonal antibodies and their use | |
| EP0146866A3 (en) | Phenylsulfonephthaleinyl-beta-d-galactosides, methods for their preparation and their use in the determination of beta-d-galactosidase | |
| EP0114777A3 (en) | Expression vehicles and their use in the preparation of a protein having human alpha-antitrypsin activity | |
| GB8417338D0 (en) | Human proteins antisera and test kits | |
| IL70686A0 (en) | Novel cell lines for use in the preparation of hybridoma cells | |
| IT1189058B (it) | Sedile in particolare per l'impiego in automobili,velivoli e abitazioni | |
| GB2153364B (en) | Lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses | |
| EP0131627A4 (en) | SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE. | |
| EP0137258A3 (en) | Zirconia-titania-silica tergels and their use as catalyst supports | |
| ZA843060B (en) | Use of alpha factor sequences in yeast expression systems | |
| IL84040A0 (en) | Monoclonal antibodies against ifn-omega,their preparation and their use in the purification and detection of ifn-omega | |
| IL73941A0 (en) | Ultrasonic detector cell and system | |
| GB2160544B (en) | Monoclonal antibody to hli and its use for purifying hli | |
| GB8403707D0 (en) | Exhaust-gas recirculation system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM9K | Patent not in force due to non-payment of renewal fees |